CClinicalTrials.gg
Active, not recruitingNCT05915559AMYAMBUUpdated Aug 24, 2025

Outpatient Management of Tonsillectomy in Adults

An interventional study of Tonsillectomy and daily follow-up in Tonsillectomy, Pain and Ambulatory, sponsored by Centre Hospitalier Universitaire, Amiens. Active, not recruiting at 1 site in France. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2025-08-24.

Sponsored by Centre Hospitalier Universitaire, Amiens · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Tonsillectomy is a frequent surgical procedure in the ENT specialty but it can be a source of postoperative pain that can be important. These pains complicate the intake of food and in particular the intake of analgesic drugs per os and require the prolongation of the hospitalization in order to continue an intravenous analgesia. The aim is to set up a protocol for ambulatory care of adult tonsillectomies. Then, it would allow an improvement of the postoperative quality of life for the patient, who prefers a quicker return home.The study aims to allow patients to come back home early after tonsillectomies with intravenous analgesia. Pain, feeding and quality of life will be evaluated regularly through an application called MAELA during a few days after surgery. They will also be evaluated by nurses coming via providers.

02

Conditions studied

  • Tonsillectomy
  • Pain
  • Ambulatory

Browse trials for

Keywords

  • Tonsillectomy
  • Pain
  • ambulatory
03

In context

Pain

2,219 studies on the registry are indexed under Pain; 917 are open to participants now.

This study's planned enrollment of 75 is close to the median of 70 across 1,904 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Centre Hospitalier Universitaire, Amiens is the lead sponsor of 576 studies on the registry; 178 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Indication for a tonsillectomy defined in the French recommendations
  • Age between 18 and 60 yo
  • Providing free and informed consent to participate
  • Having a smartphone able to process MAELA application
  • Affiliation to french social security
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
75 participants (estimated)

Study arms

  • Experimental
    Tonsillectomy

    Procedure: Tonsillectomy · Other: daily follow-up

Interventions

  • ProcedureTonsillectomy

    Tonsillectomy

  • Otherdaily follow-up

    daily follow-up of clinical parameters (pain, feeding) and analgesia adapted to the pain

06

What researchers measure

Primary outcomes

  1. Number of patients EVA score less or equal at 3

    EVA score is a pain scale from 0 to 10. 10 is the highest pain level.

    Time frame: day 1

07

Study locations

1 site
  • CHU Amiens
    Amiens, 80480, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05915559
Lead sponsor
Centre Hospitalier Universitaire, Amiens
Responsible party
Sponsor
First posted
Jun 23, 2023
Start date
Jun 1, 2023
Primary completion
May 17, 2025
Completion
Nov 2025 (estimated)
Last update
Aug 24, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion